Arrowstreet Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Arrowstreet Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-48,279	Closed	-$1.15M	–	2432
2021 Q1	$1.15M	Buy	48,279 +7,653	+19%	+$142K	﹤0.01%	1740
2020 Q4	$593K	Buy	+40,626	New	+$538K	﹤0.01%	1972

Arrowstreet Capital's GNMK Position: Q2 2021 in Review

Arrowstreet Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 48,279 shares — an estimated $1.15M sold.

Arrowstreet Capital first reported a position in GNMK in Q4 2020 and held it in 2 quarters. The position peaked at $1.15M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Arrowstreet Capital reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Arrowstreet Capital sold 48,279 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.15M.
Arrowstreet Capital first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 2 quarters.
Arrowstreet Capital's GenMark Diagnostics, Inc position peaked at $1.15M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.